ZA739534B - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
ZA739534B
ZA739534B ZA739534A ZA739534A ZA739534B ZA 739534 B ZA739534 B ZA 739534B ZA 739534 A ZA739534 A ZA 739534A ZA 739534 A ZA739534 A ZA 739534A ZA 739534 B ZA739534 B ZA 739534B
Authority
ZA
South Africa
Prior art keywords
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
ZA739534A
Other languages
English (en)
Inventor
R Clarke
D Hartley
A Oxford
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of ZA739534B publication Critical patent/ZA739534B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA739534A 1973-01-04 1973-12-18 Heterocyclic compounds ZA739534B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB55373*[A GB1457873A (en) 1973-01-04 1973-01-04 Imidazotriazines

Publications (1)

Publication Number Publication Date
ZA739534B true ZA739534B (en) 1974-11-27

Family

ID=9706420

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA739534A ZA739534B (en) 1973-01-04 1973-12-18 Heterocyclic compounds

Country Status (19)

Country Link
US (1) US3941785A (en:Method)
JP (1) JPS4995994A (en:Method)
AT (1) AT336029B (en:Method)
AU (1) AU474078B2 (en:Method)
BE (1) BE809369A (en:Method)
CA (1) CA1005057A (en:Method)
CH (1) CH618170A5 (en:Method)
DE (1) DE2364076A1 (en:Method)
ES (1) ES422001A1 (en:Method)
FI (2) FI57260C (en:Method)
FR (1) FR2213058B1 (en:Method)
GB (1) GB1457873A (en:Method)
IE (1) IE38681B1 (en:Method)
IL (1) IL43872A (en:Method)
LU (1) LU69099A1 (en:Method)
NL (1) NL7400095A (en:Method)
NO (1) NO140301C (en:Method)
SE (1) SE408179B (en:Method)
ZA (1) ZA739534B (en:Method)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
US4107309A (en) * 1977-05-23 1978-08-15 American Cyanamid Company Substituted imidazo[1,2-d]-as-triazines
US4096257A (en) * 1977-05-23 1978-06-20 American Cyanamid Company Substituted imidazo [1,2-d]-as-triazines
US4126444A (en) * 1977-11-22 1978-11-21 American Cynamid Company Substituted imidazo (1,5-D)-as-triazin-4-ols, and herbicidal use thereof
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
DD244681A3 (de) * 1985-12-02 1987-04-15 Zeiss Jena Veb Carl Vorrichtung zur positionierung von enden flexibler lichtleitelemente
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
CZ301911B6 (cs) 1997-11-12 2010-07-28 Bayer Schering Pharma Aktiengesellschaft 2-Fenylsubstituované imidazotriazinony, zpusob jejich výroby, léciva tyto látky obsahující a jejich použití
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
CN1314811A (zh) 1998-08-26 2001-09-26 史密丝克莱恩比彻姆公司 治疗肺病的方法
HU229439B1 (hu) * 1999-08-21 2013-12-30 Takeda Gmbh Roflumilast és salmeterol szinergetikus kombinációja
CN1633298A (zh) * 2001-05-09 2005-06-29 拜尔健康护理股份公司 2-苯基取代的咪唑三嗪酮的新用途
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
GB0113344D0 (en) 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
DE10130167A1 (de) * 2001-06-22 2003-01-02 Bayer Ag Imidazotriazine
DE10135815A1 (de) 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
DE10230605A1 (de) * 2002-07-08 2004-01-29 Bayer Ag Substituierte Imidazotriazine
DE10230604A1 (de) * 2002-07-08 2004-01-29 Bayer Ag Heterocyclisch substituierte Imidazotriazine
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
JP2006522127A (ja) * 2003-04-01 2006-09-28 スミスクライン ビーチャム コーポレーション イミダゾトリアジン化合物
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
AU2006299232A1 (en) * 2005-09-29 2007-04-12 Bayer Schering Pharma Aktiengesellschaft PDE inhibitors and combinations thereof for the treatment of urological disorders
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007104035A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2068872A1 (en) * 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CA2689638A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) * 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques

Also Published As

Publication number Publication date
ATA2374A (de) 1976-08-15
IE38681L (en) 1974-07-04
NO140301C (no) 1979-08-08
GB1457873A (en) 1976-12-08
JPS4995994A (en:Method) 1974-09-11
IL43872A0 (en) 1974-03-14
BE809369A (fr) 1974-07-03
FI793137A7 (fi) 1981-01-01
FI57260B (fi) 1980-03-31
AU474078B2 (en) 1976-07-15
CA1005057A (en) 1977-02-08
FR2213058A1 (en:Method) 1974-08-02
AT336029B (de) 1977-04-12
LU69099A1 (en:Method) 1974-04-02
US3941785A (en) 1976-03-02
DE2364076A1 (de) 1974-07-18
SE408179B (sv) 1979-05-21
ES422001A1 (es) 1976-08-01
IL43872A (en) 1979-01-31
CH618170A5 (en:Method) 1980-07-15
AU6377473A (en) 1975-06-19
FR2213058B1 (en:Method) 1977-07-01
NL7400095A (en:Method) 1974-07-08
NO140301B (no) 1979-04-30
FI57260C (fi) 1980-07-10
IE38681B1 (en) 1978-05-10

Similar Documents

Publication Publication Date Title
ZA739534B (en) Heterocyclic compounds
ZA74883B (en) Heterocyclic compounds
ZA741860B (en) Heterocyclic compounds
ZM16774A1 (en) Compounds
PH9846A (en) Heterocyclic anilids
ZA743407B (en) Heterocyclic organic compounds
AU474798B2 (en) Heterocyclic compounds
AU7031674A (en) Novel compounds
ZA743509B (en) Heterocyclic organic compound
AU6977274A (en) Compounds
EG11106A (en) Heterocyclic anilids
ZA747526B (en) Heterocyclic compounds
ZA746482B (en) Nitro heterocyclic compounds
ZA747255B (en) Herbicidal heterocyclic compounds
ZA747286B (en) Heterocyclic compounds
ZA741979B (en) Basically substituted heterocyclic derivatives
HK62778A (en) Pathalocyanine compounds
ZA738566B (en) Heterocyclic compounds
ZA741859B (en) Heterocyclic compounds
AU7072074A (en) Heterocyclic compounds
AU7040074A (en) Compounds
GB1401167A (en) Heterocyclic substituted thiopropanamides
IL45789A (en) Antimicrobial dihalonitromethyl heterocyclic compounds
ZA744584B (en) Novel n-hydroxy-amidine compounds
ZA746694B (en) Heterocyclic compounds